A licensing deal with Denmark’s Gubra gives the immunology giant control of an experimental therapy that could compete with ...

Though the Healthy Skepticism ads don’t specifically call out compounded GLP-1s, Lilly said in a statement to MM+M that ...

Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...

California dedicated $100 to manufacturing insulin for diabetic residents. That effort is taking longer than Gov. Gavin Newsom's initial timeline.

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

Hims & Hers Health (HIMS) is an intriguing stock strategically positioned in the rapidly expanding telehealth market. However, this week’s ...

Outsourcing Facilities Association and North American Custom Laboratories allege the FDA removed semaglutide from its ...

New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...

Novavax (NVAX) reported a large fourth quarter sales decline Thursday — and said it no longer wants to be known simply as a ...

The drugmaker Novo Nordisk can meet current and future demand in the U.S ... during the shortage will have to wind down production in the next few months, the FDA said. In December, the agency said ...

Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...

Today we'll look at six European stocks that could continue outperforming in 2025. Some of these companies are available to ...